Suppr超能文献

华法林群体药代动力学和药效学的种族差异。

Ethnic differences in the population pharmacokinetics and pharmacodynamics of warfarin.

机构信息

Global PK/PD/TS, Eli Lilly & Co. Ltd., Windlesham Surrey, UK.

出版信息

J Pharmacokinet Pharmacodyn. 2010 Feb;37(1):3-24. doi: 10.1007/s10928-009-9138-4. Epub 2009 Nov 26.

Abstract

Ethnic differences in warfarin maintenance doses have been documented amongst the three major Asian ethnic groups (Chinese, Malay and Indian) in Singapore. Studies have shown that cytochrome P450 2C9 (CYP2C9) polymorphisms alone did not entirely account for these differences. Recent reports suggest that VKORC1 (subunit of vitamin K epoxide reductase) haplotypes are more predictive of warfarin response. Population pharmacokinetic/pharmacodynamic (PK/PD) modelling techniques were employed to characterise the PK and PD of warfarin in a healthy volunteer study of 16 Chinese and Indian subjects following a single 25 mg dose of warfarin. To further investigate the underlying differences in warfarin response, a semi-mechanistic modelling approach (using an indirect response model for PCA activity) incorporating the vitamin K cycle was attempted using population methods with Bayesian inference. All eight Indian subjects had H7H7 VKORC1 haplotypes and three had either *2/wt or *3/wt CYP2C9 genotypes. Six Chinese subjects had H1H1 VKORC1 haplotypes and one had H1H7. All Chinese subjects were homozygous wt/wt for CYP2C9. Simulations to steady state were performed to examine warfarin response in subjects with different CYP2C9 and VKORC1 polymorphisms. The presence of a single *2 or *3 CYP2C9 allele reduced mean [SE (standard error)] S-warfarin clearance by 35% from 0.276 (0.04) to 0.180 (0.11) l/h. Subjects with VKORC1 haplotype groups of H7H7 had increased mean (SE) C (50,S) (concentration of S-warfarin required to achieve 50% of maximum effect) of 479 (7.3) compared to 206 (6.7) ng/ml in subjects with the H1H1 groups. For subjects with the H1H7 haplotype, mean (SE) C (50,S) increased 1.4 times to 288 (1.3) ng/ml compared to subjects with H1H1 haplotypes. Steady state simulations showed that whilst CYP2C9 polymorphisms affect the PK of warfarin, VKORC1 haplotypes may be better predictors of warfarin response. Since 90% of Chinese subjects had the VKORC1 H1 haplotype and 100% of Indian subjects the H7 haplotype in this study, ethnic differences in warfarin response in this study appear to be linked to differences in VKORC1 haplotypes.

摘要

在新加坡的三大亚洲族群(华人、马来人和印度人)中,已经有研究记录了华法林维持剂量的种族差异。研究表明,细胞色素 P450 2C9(CYP2C9)多态性并不能完全解释这些差异。最近的报告表明,维生素 K 环氧化物还原酶亚单位 1(VKORC1)单倍型对华法林反应的预测性更高。采用群体药代动力学/药效动力学(PK/PD)模型技术,对 16 名中国和印度健康志愿者单次服用 25 毫克华法林后的 PK 和 PD 进行了特征描述。为了进一步研究华法林反应的潜在差异,使用间接反应模型(用于 PCA 活性),结合维生素 K 循环,采用群体方法和贝叶斯推断尝试了一种半机械建模方法。所有 8 名印度受试者均具有 VKORC1 H7H7 单倍型,其中 3 名受试者具有 CYP2C92/wt 或 CYP2C93/wt 基因型。6 名中国受试者具有 VKORC1 H1H1 单倍型,1 名受试者具有 H1H7。所有中国受试者 CYP2C9 均为纯合 wt/wt。进行稳态模拟以检查具有不同 CYP2C9 和 VKORC1 多态性的受试者的华法林反应。单个 CYP2C92 或3 等位基因的存在使 S-华法林清除率平均(SE(标准误差))降低 35%,从 0.276(0.04)降至 0.180(0.11)l/h。VKORC1 单倍型组为 H7H7 的受试者的平均(SE)C(50,S)(达到 50%最大效应所需的 S-华法林浓度)为 479(7.3)ng/ml,而 H1H1 组为 206(6.7)ng/ml。对于具有 H1H7 单倍型的受试者,平均(SE)C(50,S)增加了 1.4 倍,达到 288(1.3)ng/ml,而具有 H1H1 单倍型的受试者则增加了 1.4 倍。稳态模拟表明,虽然 CYP2C9 多态性会影响华法林的 PK,但 VKORC1 单倍型可能是华法林反应的更好预测指标。由于本研究中 90%的中国受试者具有 VKORC1 H1 单倍型,而 100%的印度受试者具有 H7 单倍型,因此本研究中,华法林反应的种族差异似乎与 VKORC1 单倍型的差异有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验